Investment Focus

DRI Capital seeks to invest in royalty entitlements on healthcare products which are safe, efficacious and have a compelling value proposition.

High Quality Products

+

High Quality Products

We invest in products that exhibit a safe and efficacious profile and are medically necessary for patients to improve their health or quality of life, delivering a meaningful impact to the patient population. These products are typically used to treat chronic, critical or rare diseases.

Leading Marketers

+

Leading Marketers

We seek products that are sold by high quality marketers. This includes large pharmaceutical and biotechnology companies and companies with a particular expertise in a specific, relevant segment of the pharmaceutical industry or therapeutic area.

Protected Cash Flows

+

Protected Cash Flows

We invest in products that benefit from strong patent and/or regulatory protection and focus on products protected from generic and biosimilar competition.